Polar Capital Holdings PLC Verona Pharma PLC Transaction History

Polar Capital Holdings PLC

  • $16.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$5.29 - $6.35 $4.76 Million - $5.72 Million
-900,000 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$5.72 - $9.09 $572,000 - $909,000
-100,000 Reduced 10.0%
900,000 $5.89 Million
Q1 2021

May 17, 2021
SELL
$7.08 - $9.33 $4.43 Million - $5.83 Million
-625,000 Reduced 38.46%
1,000,000 $8.36 Million
Q4 2020

Feb 16, 2021
BUY
$5.51 - $8.11 $8.95 Million - $13.2 Million
1,625,000 New
1,625,000 $11.4 Million

Others Institutions Holding VRNA

# of Institutions
167
Shares Held
68.7M
Call Options Held
704K
Put Options Held
685K
View Full List

About Verona Pharma plc

VRNA Quotes by TradingView
  • Ticker VRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,954,200
  • Market Cap $2.84B
  • Description
  • Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...
More about VRNA
Track This Portfolio

Track Polar Capital Holdings PLC Portfolio

Follow Polar Capital Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Polar Capital Holdings PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email